Detalles de la búsqueda
1.
Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia.
Mol Ther Nucleic Acids;
35(2): 102202, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38846999
2.
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Cancer Med;
13(9): e7235, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716626
3.
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50).
Esophagus;
20(2): 291-301, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401133
4.
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576.
Adv Hematol;
2022: 4450824, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35103064
5.
Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Leuk Lymphoma;
62(13): 3278-3282, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34384312
6.
Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry.
Clin Lymphoma Myeloma Leuk;
20(3): 174-183.e3, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32033927
7.
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
J Hematol Oncol;
10(1): 112, 2017 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526063
8.
Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
Best Pract Res Clin Haematol;
29(1): 79-89, 2016 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27742074
9.
Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.
Oncotarget;
7(3): 2809-22, 2016 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26646452
10.
Respuesta inflamatoria en pacientes con un primer ataque cerebrovascular isquémico: evaluación por género / Inflammatory response in a first ischemic stroke: differences by gender
Acta neurol. colomb;
30(1): 6-15, ene.-mar. 2014. ilus, tab
Artículo
en Español
| LILACS | ID: lil-724883
Resultados
1 -
10
de 10
1
Próxima >
>>